John Holcomb
Board Member
MiNK Therapeutics, Inc. (INKT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John Holcomb
John Holcomb is recorded as Board Member at MiNK Therapeutics, Inc. (INKT). MiNK Therapeutics, Inc. reported in an 8-K filed September 29, 2025 that John Holcomb was appointed Class II director, effective September 23, 2025.
“On September 23, 2025, the Board of Directors (the "Board") of MiNK Therapeutics, Inc., ("MiNK") elected Dr. John Holcomb to become a Class II director of MiNK with an initial term that expires at MiNK's annual meeting of stockholders in 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-09-23–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at MiNK Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Melissa Orilall CFO
- Austin Charette Chief Accounting Officer
- Dr. John Holcomb Board Member
- Jennifer Buell Board Member
- Peter Behner Board Member
- Robert Kadlec Board Member
- Ulf Wiinberg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.